NCT06558448

Brief Summary

This study is a multicenter retrospective research aimed at developing a heart failure prognosis warning system based on multimodal clinical data to improve the diagnosis and treatment of heart failure. This study aims to address the following main questions:

  1. 1.What are the clinical characteristics and current treatment status of heart failure patients?
  2. 2.What factors influence the onset of heart failure and the prognosis of patients?
  3. 3.How can real-world big data be utilized to construct an accurate heart failure prognosis assessment model?
  4. 4.How can this prognosis assessment model help improve the therapeutic effects and quality of life for heart failure patients?

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2024

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2024

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

August 14, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 16, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

August 16, 2024

Status Verified

August 1, 2024

Enrollment Period

4 months

First QC Date

August 14, 2024

Last Update Submit

August 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • In-hospital mortality or other adverse outcomes, including readmission, in-hospital infection, respiratory failure, liver failure, and renal failure.

    The study focuses on evaluating the risk factors and predictors of in-hospital mortality and various adverse outcomes in heart failure patients, encompassing events such as readmission due to exacerbation of the condition, infections acquired during hospital stay, critical impairments in respiratory, liver, and kidney functions that may complicate the clinical course and impact patient prognosis.

    Evaluations will be conducted within 30, 60, or 90 days post-admission for heart failure patients to assess the impact of the condition and the effectiveness of treatment.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population for this research consists of adult patients, aged 18 and above, with a discharge diagnosis of heart failure between January 2011 and December 2024, as per the guidelines for the diagnosis and treatment of heart failure . The patients' electronic medical records, which include demographic information, comorbidities, treatment plans, and various clinical indicators, are sourced , ensuring a comprehensive and in-depth analysis of the heart failure patient cohort.

You may qualify if:

  • Age Requirement: We plan to include adult patients aged 18 and above to ensure the study covers a broad spectrum of the adult heart failure patient population.
  • Diagnostic Criteria: Patients should have a discharge diagnosis of heart failure according to the guidelines for heart failure diagnosis and treatment.
  • Time Frame: The discharge time of patients should be between January 2011 and December 2024 to collect and analyze data from the past several years.
  • Data Integrity: There is a preference for including medical records with high data integrity, but the specific criteria may be adjusted according to the actual situation of the dataset.

You may not qualify if:

  • Diagnostic Inconsistency: Patients with unclear diagnoses or potential for confusion with other diseases may be excluded to ensure the specificity of the study.
  • Non-standard Treatment: Patients who have not received treatment according to the established treatment protocol may be excluded to reduce the impact of treatment variability on the study results.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
student

Study Record Dates

First Submitted

August 14, 2024

First Posted

August 16, 2024

Study Start

August 1, 2024

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

August 16, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

The data analyzed in this study are subject to the following licenses/restrictions: due to ethics committee regulations, the access to the dataset supporting the findings of this study is limited and not public. Requests to access these datasets should be directed to XZ Liu(xiaozhuliu2021@163.com).